Stocksigma LogoStocksigma Logo

Advanced Enzyme Technologies Schedules Board Meeting to Approve Q2 Results

Advanced Enzyme Technologies Limited announced that its Board of Directors is scheduled to meet on 31st Oct'26 to consider and approve the unaudited

Advanced Enzyme Technologies Schedules Board Meeting to Approve Q2 Results

Advanced Enzyme Technologies Ltd 路 Intimation 路 31 Oct 2026, 5:30 am

Advanced Enzyme Technologies Schedules Board Meeting to Approve Q2 Results Advanced Enzyme Technologies Limited announced that its Board of Directors is scheduled to meet on 31st Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In connection with the results announcement, the trading window for dealing in the company's securities will remain closed until 2nd Nov'26.

Original exchange filing (PDF)

More announcements from Advanced Enzyme Technologies Ltd

All Advanced Enzyme Technologies Ltd announcements